Drug Type Enzyme |
Synonyms Ocriplasmin, 重组人截短型纤溶酶(景泽生物), JZB-32 |
Target |
Action inhibitors |
Mechanism fibrin inhibitors(Fibrin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Polypoidal choroidal vasculopathy | Phase 1 | China | 19 Aug 2024 | |
| Polypoidal choroidal vasculopathy | Phase 1 | China | 19 Aug 2024 | |
| Vitreomacular Adhesion | Phase 1 | China | 27 Oct 2022 | |
| Vitreomacular Adhesion | Phase 1 | China | 27 Oct 2022 |






